Brinker Capital’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$1.24M	Buy	11,037 +701	+7%	+$74.4K	0.04%	444
2020 Q1	$928K	Buy	10,336 +3,096	+43%	+$304K	0.04%	445
2019 Q4	$783K	Sell	7,240 -1,611	-18%	-$172K	0.02%	586
2019 Q3	$867K	Buy	8,851 +684	+8%	+$77.1K	0.03%	535
2019 Q2	$1.07M	Sell	8,167 -1,909	-19%	-$246K	0.04%	445
2019 Q1	$1.36M	Buy	10,076 +3,364	+50%	+$418K	0.05%	370
2018 Q4	$653K	Sell	6,712 -870	-11%	-$103K	0.03%	527
2018 Q3	$1.05M	Buy	7,582 +1,804	+31%	+$226K	0.04%	484
2018 Q2	$717K	Buy	5,778 +93	+2%	+$10.9K	0.03%	599
2018 Q1	$634K	Buy	5,685 +962	+20%	+$115K	0.02%	630
2017 Q4	$565K	Buy	4,723 +159	+3%	+$19.4K	0.02%	649
2017 Q3	$640K	Buy	+4,564	New	+$620K	0.03%	580
2017 Q2	–	Sell	-3,493	Closed	-$423K	–	921
2017 Q1	$423K	Sell	3,493 -560	-14%	-$72.2K	0.02%	649
2016 Q4	$496K	Buy	+4,053	New	+$496K	0.03%	456